To evaluate the impact of Dsg2 on invasive properties of melanoma cells independent of their migratory capacities, we used a TEER breakdown assay, which allows to measure cancer cell-monolayer violation at the very beginning of invasion with a very high sensitivity [26]–[29]. The gene discussed is DSG2; the disease is cancer.